These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 28285366)

  • 1. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
    Barton V; Armeson K; Hampras S; Ferris LK; Visvanathan K; Rollison D; Alberg AJ
    Arch Dermatol Res; 2017 May; 309(4):243-251. PubMed ID: 28285366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
    Marcil I; Stern RS
    Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
    Stern RS
    Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
    Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
    J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
    Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
    JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: a single-center experience in São Paulo, Brazil.
    Hayashida MZ; Fernandes VM; Fernandes DR; Ogawa MM; Tomimori J
    Int J Dermatol; 2015 Oct; 54(10):e383-8. PubMed ID: 25969871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review.
    Perera E; Gnaneswaran N; Staines C; Win AK; Sinclair R
    Australas J Dermatol; 2015 Nov; 56(4):258-67. PubMed ID: 25716064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
    Lewis KG; Weinstock MA
    Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
    Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
    J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
    van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
    Dai H; Li WQ; Qureshi AA; Han J
    J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte Carcinoma as a Marker of a High Cancer-Risk Phenotype.
    Small J; Barton V; Peterson B; Alberg AJ
    Adv Cancer Res; 2016; 130():257-91. PubMed ID: 27037755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of nonmelanoma skin cancer.
    Strom SS; Yamamura Y
    Clin Plast Surg; 1997 Oct; 24(4):627-36. PubMed ID: 9342506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing demographics and pathology of nonmelanoma skin cancer in the last 30 years.
    Collins GL; Nickoonahand N; Morgan MB
    Semin Cutan Med Surg; 2004 Mar; 23(1):80-3. PubMed ID: 15095919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.
    Nugent Z; Demers AA; Wiseman MC; Mihalcioiu C; Kliewer EV
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2584-90. PubMed ID: 16284382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis.
    Rees JR; Zens MS; Celaya MO; Riddle BL; Karagas MR; Peacock JL
    Int J Cancer; 2015 Aug; 137(4):878-884. PubMed ID: 25598534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors.
    Healy E; Collins P; Barnes L
    Ir Med J; 1995; 88(2):58-9. PubMed ID: 7775148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.